Britton Boras

10PUBLICATIONS
109CO-AUTHORS
Nanotoxicology, health and safetyMajor global burdens of diseaseMolecular targetsCheminformatics and quantitative structure-activity relationshipsLife cycle assessment and industrial ecology
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (10)

|Aug 01, 2026
The 5'-Isobutyryl Ester Prodrug of 4'-Thiouridine Inhibits SARS-CoV‑2 Replication in Culture and in a Syrian Hamster Infection Model.

|Aug 01, 2026
Utilizing Virtual Clinical Trials to Inform Target Coverage That Drives RSV Antiviral Efficacy.

|Dec 05, 2025
Discovery of Atirmociclib (PF-07220060): A Potent and Selective CDK4 Inhibitor.

Gary M Gallego, Cynthia Palmer, Suvi Orr

|Mar 21, 2025
18F-FLT PET, a Noninvasive Pharmacodynamic Biomarker of Tumor Cell Proliferation, Detected Differential Response to Various Cyclin-Dependent Kinase (CDK) Inhibitors.

Anand Giddabasappa, Ziyue Karen Jiang, Bing Yang

|Feb 28, 2025
Discovery of Nirmatrelvir (PF-07321332): A Potent, Orally Active Inhibitor of the Severe Acute Respiratory Syndrome Coronavirus 2 (SARS CoV-2) Main Protease.

Jamison B Tuttle, Christophe Allais, Charlotte M N Allerton

|Oct 16, 2024
Quantitative systems toxicology modeling in pharmaceutical research and development: An industry-wide survey and selected case study examples.

Kylie A Beattie, Meghna Verma, Richard J Brennan

Pageof 2

Frequent Collaborators

5 joint publications

Amit S Kalgutkar

4 joint publications

Nandini C Patel

3 joint publications

Li Di

3 joint publications

Matthew F Sammons